RESEARKA

Mechanistically, the studies touch on pathways central to rapamycin's action. Lesniewski 2016 reports that dietary rapamycin reverses age-related vascular dysfunction and oxidative stress while modulating nutrient-sensing, cell cycle, and senescence pathways. Shavlakadze 2018 provides preclinical data suggesting short-term, low-dose mTORC1 inhibition in aged rats can counter-regulate age-related gene expression changes and block age-related kidney pathology. Harinath 2025's observational data in humans provides a translational bridge, examining whether the mechanistic effects observed in models translate to measurable blood levels in aging individuals using real-world compounded or commercial formulations. The case report by Britton 2025, while mechanistically limited, posits a potential interaction with low-dose naltrexone leading to a positive bone density outcome.

Citation Support

• source_1 Moel 2025
• source_2 Gkioni 2025
• source_3 Smiaek 2023
• source_4 Willows 2023
• source_5 Harinath 2025